LabCorp v. Metabolite Supreme Court Case Puts Patent World On Edge
Executive Summary
A case recently argued before the Supreme Court could have broad implications in the pharmaceutical industry for patents covering natural phenomena
You may also be interested in...
Licensing Deals May Become More Adversarial Following MedImmune Ruling
The Supreme Court's ruling that MedImmune is entitled to challenge a patent it is licensing from Genentech will likely create a more contentious environment for parties negotiating licensing deals
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011